Patents by Inventor Michael Clare-Salzler

Michael Clare-Salzler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Materials and methods for detection and treatment of immune system dysfunctions
    Patent number: 6953578
    Abstract: The subject invention concerns novel materials and methods for the treatment and/or prevention of autoimmune disease. In a specific embodiment, elevated production of prostaglandin synthase-2 (PGS-2) is correlated with autoimmune dysfunction.
    Type: Grant
    Filed: March 29, 2001
    Date of Patent: October 11, 2005
    Assignee: University of Florida Research Foundation, Inc.
    Inventor: Michael Clare-Salzler
  • Methods and compositions for expressing a nucleic acid in a dendritic cell
    Publication number: 20040072351
    Abstract: Recombinant adeno-associated virus (rAAV) virions having a serotype 1 capsid protein are effective for transferring heterologous nucleic acids into DC.
    Type: Application
    Filed: April 30, 2003
    Publication date: April 15, 2004
    Inventors: Karl L. Womer, Sihong Song, Terence R. Flotte, Scott A. Loiler, Mark A. Atkinson, Michael Clare-Salzler, Jude Samulski, Chengwin Li
  • Materials and methods for detection and treatment of immune system dysfunctions
    Patent number: 6218133
    Abstract: The subject invention concerns novel materials and methods for the treatment and/or prevention of autoimmune disease. In a specific embodiment, elevated production of prostaglandin synthase-2 (PGS-2) is correlated with autoimmune dysfunction.
    Type: Grant
    Filed: May 28, 1999
    Date of Patent: April 17, 2001
    Assignee: University of Florida
    Inventor: Michael Clare-Salzler
  • Materials and methods for detection and treatment of immune system dysfunctions
    Patent number: 6168792
    Abstract: The subject invention concerns novel materials and methods for the treatment and/or prevention of autoimmune disease. In a specific embodiment, elevated production of prostaglandin synthase-2 (PGS-2) is correlated with autoimmune dysfunction.
    Type: Grant
    Filed: August 22, 1997
    Date of Patent: January 2, 2001
    Assignee: University of Florida
    Inventor: Michael Clare-Salzler
  • Materials and methods for detection and treatment of immune system dysfunctions
    Patent number: 5939069
    Abstract: The subject invention concerns novel materials and methods for the treatment and/or prevention of autoimmune disease. In a specific embodiment, elevated production of prostaglandin synthase-2 (PGS-2) is correlated with autoimmune dysfunction.
    Type: Grant
    Filed: August 23, 1996
    Date of Patent: August 17, 1999
    Assignee: University of Florida
    Inventor: Michael Clare-Salzler